Gastric lavage: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
#Of limited/infrequent utility | |||
#Almost never used in conscious and cooperative patients should be minimal (< 5% of presentations) | |||
#restricted to poisonings where benefits over oral [[Activated Charcoal]] are likely | |||
- | ==Indications== | ||
# Life-threatening poisoning (or history is not available) and unconscious presentation | |||
# Life-threatening poisoning and presentation within 1 hour | |||
# Life-threatening poisoning with drug with anticholinergic effects and presentation within 4 hours | |||
# Ingestions of sustained release preparation of significantly toxic drug | |||
# Large salicylate poisonings presenting within 12 hours | |||
# Iron or lithium poisoning | |||
==Contraindications== | |||
===Absolute=== | |||
# Corrosive ingestions or oesophageal disease | |||
- | ==Technique== | ||
# Protect airway (endotracheal intubation) if patient is stuporous or comatose | |||
# Lie patient on their left side | |||
# Insert a large bore double lumen orogastric tube | |||
# Aspirate stomach contents | |||
# Use a small cycle lavage of 50-100 mL (and then aspirate) | |||
# Lavage is rarely indicated beyond 5 minutes, unless tablets are still actively being returned | |||
It is no longer recommended to have a completely clear return before ceasing gastric lavage. | |||
==Complications== | |||
# Increase gastric delivery of tablets into the small bowel | |||
# Aspiration of gastric contents (3% of patients) | |||
# [[Esophageal Rupture]] (rare) | |||
# Profound bradycardia, cardiac arrest, and asystole may be precipitated by lavage in poisonings with propranolol, calcium channel blockers and other drugs affecting cardiac conduction | |||
##Atropine should be used to block the increased vagal tone associated with the procedure in these situations | |||
== | ==See Also== | ||
[[Activated Charcoal]] | |||
== | ==Source== | ||
Vale JA. Position statement: gastric lavage. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997;35(7):711-9 | |||
[[Category:Procedures]] | [[Category:Procedures]] | ||
[[Category:Tox]] | [[Category:Tox]] | ||
Revision as of 04:25, 17 July 2011
Background
- Of limited/infrequent utility
- Almost never used in conscious and cooperative patients should be minimal (< 5% of presentations)
- restricted to poisonings where benefits over oral Activated Charcoal are likely
Indications
- Life-threatening poisoning (or history is not available) and unconscious presentation
- Life-threatening poisoning and presentation within 1 hour
- Life-threatening poisoning with drug with anticholinergic effects and presentation within 4 hours
- Ingestions of sustained release preparation of significantly toxic drug
- Large salicylate poisonings presenting within 12 hours
- Iron or lithium poisoning
Contraindications
Absolute
- Corrosive ingestions or oesophageal disease
Technique
- Protect airway (endotracheal intubation) if patient is stuporous or comatose
- Lie patient on their left side
- Insert a large bore double lumen orogastric tube
- Aspirate stomach contents
- Use a small cycle lavage of 50-100 mL (and then aspirate)
- Lavage is rarely indicated beyond 5 minutes, unless tablets are still actively being returned
It is no longer recommended to have a completely clear return before ceasing gastric lavage.
Complications
- Increase gastric delivery of tablets into the small bowel
- Aspiration of gastric contents (3% of patients)
- Esophageal Rupture (rare)
- Profound bradycardia, cardiac arrest, and asystole may be precipitated by lavage in poisonings with propranolol, calcium channel blockers and other drugs affecting cardiac conduction
- Atropine should be used to block the increased vagal tone associated with the procedure in these situations
See Also
Source
Vale JA. Position statement: gastric lavage. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997;35(7):711-9
